Article
Inhibition of CRISPR/Cas9-Mediated Genome Engineering by a Type I Interferon-Induced Reduction in Guide RNA Expression.
Biological & pharmaceutical bulletin - 1 Jan 2017
Machitani Mitsuhiro, Sakurai Fuminori, Wakabayashi Keisaku, Nakatani Kosuke, Takayama Kazuo, Tachibana Masashi, Mizuguchi Hiroyuki
Abstract excerpt
Clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9-mediated genome engineering technology is a powerful tool for generation of cells and animals with engineered mutations in their genomes. In order to introduce the CRISPR/Cas9 system into target cells, nonviral and viral vectors are often used; however, such vectors trigger innate immune responses associated with production of type I...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
